Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 7, 2012
An Hsp90 modulator that exhibits a unique mechanistic profile
Deborah M Ramsey, Jeanette R McConnell, Leslie D Alexander, et al.
Medchemcomm
|
March 26, 2013
A structure-activity relationship study on multi-heterocyclic molecules: two linked thiazoles are required for cytotoxic activity
Seong Jong Kim, Chun Chieh Lin, Chung-Mao Pan, et al.
ACS Medicinal Chemistry Letters
|
August 24, 2010
Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90
Robert C Vasko, Rodrigo A Rodriguez, Christian N Cunningham, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
September 6, 2019
C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway
Nalin Kataria, Chloe-Anne Martinez, Bernadette Kerr, et al.
Organic Letters
|
December 22, 2007
Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles
Melinda R Davis, Thomas J Styers, Rodrigo A Rodriguez, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2013
A potential rhodium cancer therapy: studies of a cytotoxic organorhodium(I) complex that binds DNA
Jeanette R McConnell, Dimple P Rananaware, Deborah M Ramsey, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2011
Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90
Joseph B Kunicki, Mark N Petersen, Leslie D Alexander, et al.
ACS Medicinal Chemistry Letters
|
July 23, 2014
Chemically accessible hsp90 inhibitor that does not induce a heat shock response
Yen Chin Koay, Jeanette R McConnell, Yao Wang, et al.
Bioorganic & Medicinal Chemistry
|
April 4, 2006
Novel antibiotics: C-2 symmetrical macrocycles inhibiting Holliday junction DNA binding by E. coli RuvC
Po-Shen Pan, Fiona A Curtis, Chris L Carroll, et al.
Organic Letters
|
January 17, 2003
Novel antibiotics: macrocyclic peptides designed to trap Holliday junctions
Megan L Bolla, Enrique V Azevedo, Jason M Smith, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry Letters
|
April 7, 2012
An Hsp90 modulator that exhibits a unique mechanistic profile
Deborah M Ramsey, Jeanette R McConnell, Leslie D Alexander, et al.
Medchemcomm
|
March 26, 2013
A structure-activity relationship study on multi-heterocyclic molecules: two linked thiazoles are required for cytotoxic activity
Seong Jong Kim, Chun Chieh Lin, Chung-Mao Pan, et al.
ACS Medicinal Chemistry Letters
|
August 24, 2010
Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90
Robert C Vasko, Rodrigo A Rodriguez, Christian N Cunningham, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
September 6, 2019
C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway
Nalin Kataria, Chloe-Anne Martinez, Bernadette Kerr, et al.
Organic Letters
|
December 22, 2007
Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles
Melinda R Davis, Thomas J Styers, Rodrigo A Rodriguez, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2013
A potential rhodium cancer therapy: studies of a cytotoxic organorhodium(I) complex that binds DNA
Jeanette R McConnell, Dimple P Rananaware, Deborah M Ramsey, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 19, 2011
Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90
Joseph B Kunicki, Mark N Petersen, Leslie D Alexander, et al.
ACS Medicinal Chemistry Letters
|
July 23, 2014
Chemically accessible hsp90 inhibitor that does not induce a heat shock response
Yen Chin Koay, Jeanette R McConnell, Yao Wang, et al.
Bioorganic & Medicinal Chemistry
|
April 4, 2006
Novel antibiotics: C-2 symmetrical macrocycles inhibiting Holliday junction DNA binding by E. coli RuvC
Po-Shen Pan, Fiona A Curtis, Chris L Carroll, et al.
Organic Letters
|
January 17, 2003
Novel antibiotics: macrocyclic peptides designed to trap Holliday junctions
Megan L Bolla, Enrique V Azevedo, Jason M Smith, et al.
Page
of 7